Francis Levi

Francis Levi is the foremost clinical pioneer of cancer chronotherapy, demonstrating through landmark clinical trials that time-of-day administration of 5-fluorouracil and oxaliplatin significantly improves efficacy and reduces toxicity in colorectal cancer patients. His research established that circadian variation in drug metabolism, DNA repair capacity, and cell cycle phase distribution in tumors creates exploitable therapeutic windows for chemotherapy. He developed programmable chronomodulated infusion pumps enabling precise circadian drug delivery in clinical practice. His clinical trials showed that sex-dependent circadian differences influence optimal chronotherapy schedules.